Skip to Main Content

WASHINGTON — Alex Azar defended the drug pricing proposals in the Trump administration’s latest budget request Thursday, pushing back on criticism that none of the ideas would lower the list prices for prescription drugs.

The new health and human services secretary, when pressed on the matter by both a Democratic and a Republican senator at a budget hearing, pointed to two concrete proposals by the administration. Both take aim at Medicare’s prescription drug benefit. One would put insurers, rather than the federal government, on the hook for more of the cost; another aims to encourage insurance companies to push cheaper generic drugs instead of costly brand drugs to their patients.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED